Composition
- Active ingredients
- CABOZANTINIB 20MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CABOZANTINIB 20MG · TabletANDA220121-002 · Tentative approval
- CABOZANTINIB 40MG · TabletANDA220121-003 · Tentative approval
- CABOZANTINIB 40MG · TabletANDA213878-002 · Tentative approval
- CABOZANTINIB 20MG · TabletThis page
- CABOZANTINIB 40MG · TabletANDA215942-002 · Prescription
- CABOZANTINIB 60MG · TabletANDA215942-003 · Prescription
- CABOZANTINIB 20MG · TabletANDA215942-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA213878.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Cabozantinib
- Dosage form
- Tablet
- Applicant
- MSN Laboratories Private LTD
- Status
- Tentative approval
- FDA approval
- 21 Jul 2025
- Application
- ANDA213878-003